Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - TOTAL CURRENT LIABILITIES
Total Current Liabilities AKBA - Akebia Therapeutics, Inc.
99.9 M
LAST VALUE
-37.60%
2 YEAR CAGR
-17.77%
5 YEAR CAGR
38.30%
10 YEAR CAGR